Bank of America Corp DE Sells 258,736 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Bank of America Corp DE decreased its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 57.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 187,819 shares of the company's stock after selling 258,736 shares during the period. Bank of America Corp DE owned approximately 0.15% of Henry Schein worth $12,997,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the company. BNP Paribas Financial Markets raised its stake in shares of Henry Schein by 20.4% during the fourth quarter. BNP Paribas Financial Markets now owns 222,057 shares of the company's stock valued at $15,366,000 after purchasing an additional 37,575 shares in the last quarter. Ananym Capital Management LP acquired a new position in Henry Schein during the 4th quarter valued at about $32,628,000. Palestra Capital Management LLC bought a new stake in shares of Henry Schein during the 4th quarter worth about $182,988,000. Jane Street Group LLC raised its position in shares of Henry Schein by 18.2% during the 4th quarter. Jane Street Group LLC now owns 25,556 shares of the company's stock worth $1,768,000 after buying an additional 3,932 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC lifted its stake in shares of Henry Schein by 357.6% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 24,511 shares of the company's stock worth $1,696,000 after acquiring an additional 19,154 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Trading Down 0.4%

Henry Schein stock traded down $0.32 during midday trading on Wednesday, reaching $73.34. The stock had a trading volume of 100,197 shares, compared to its average volume of 1,657,007. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market cap of $8.93 billion, a price-to-earnings ratio of 30.20, a PEG ratio of 2.13 and a beta of 0.87. The firm's fifty day simple moving average is $67.54 and its two-hundred day simple moving average is $71.58.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue was down .1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.10 earnings per share. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on HSIC. Barrington Research lowered their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Piper Sandler cut their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Wells Fargo & Company dropped their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Finally, UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein has a consensus rating of "Moderate Buy" and a consensus price target of $79.30.

Insider Buying and Selling

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. This trade represents a 9.50% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.